Jinsong Pan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jinsong Pan has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
Qing Wang
Department of Stomatology Shanghai General Hospital Shanghai Jiao Tong University School of Medicine Shanghai 200080 China
7 shared publicationsXuan Wang
Department of Stomatology Shanghai General Hospital Shanghai Jiao Tong University School of Medicine Shanghai 200080 China
5 shared publicationsShiwei Wang
Department of stomatology, Shanghai General Hospital Shanghai Jiao Tong University School of Medicine Shanghai China
3 shared publicationsXiaojie Yang
Department of stomatology, Shanghai General Hospital Shanghai Jiao Tong University School of Medicine Shanghai China
3 shared publicationsYanzheng Chen
School of Chemistry and Chemical Engineering Shanghai Jiao Tong University Shanghai 201100 China
3 shared publicationsHang Zhang
State Key Laboratory of Mechanical System and Vibration School of Mechanical Engineering Shanghai Jiao Tong University Shanghai 200240 China
2 shared publications
Latest Publications
- 2 July 2026
- Published by Springer Nature in International Journal of Clinical Oncology
- Vol. 31 (9) , 2043-2052
Impact of periodontitis on the efficacy of neoadjuvant immunochemotherapy in non-small cell lung cancer: a multi-center real-world study
Neoadjuvant immunochemotherapy has revolutionized non-small cell lung cancer(NSCLC) treatment. Periodontitis(PD) is one of the most prevalent oral diseases worldwide; however, its influence on the efficacy of neoadjuvant immunochemotherapy in NSCLC remains unclear. This study aimed to evaluate the association between PD status and severity with treatment outcomes following neoadjuvant immunochemotherapy in NSCLC. Patients with initial stage IIA-IIIB NSCLC(excluding T4N2 and N3) who underwent surgery after neoadjuvant immunochemotherapy at three institutions between 2019 and 2025 were retrospectively reviewed. Stabilized inverse probability of treatment weighting(IPTW) was employed to balance baseline characteristics. The primary endpoint was major pathological response(MPR) rates. A total of 51 non-PD and 331 PD cases were included. After IPTW adjustment, PD was associated with lower MPR(33.5% vs. 43.5%, adjusted P = 0.036) and complete pathological response rates, as well as poorer early survival. Increasing PD severity was identified as an independent risk factor for diminished therapeutic efficacy. Specifically, grade II-III PD, but not grade I PD, was associated with poorer pathological response and preliminary survival outcomes. Interaction analyses revealed that such associative patterns were modified by age and body mass index(BMI). Subsequent stratified analyses confirmed that grade II-III PD was correlated with impaired pathological response and early survival in younger(age < 65 years) and non-overweight(BMI ≤ 24.0 kg/m2) patients, but not in older(age ≥ 65 years) and overweight(BMI > 24.0 kg/m2) patients. PD may be an unfavorable prognostic factor associated with clinical outcomes of neoadjuvant immunochemotherapy in NSCLC. Grade II-III PD may be associated with worse pathological response and early survival, with more pronounced adverse effects in younger and non-overweight patients.
- 2 July 2026
- Published by Springer Nature in International Journal of Clinical Oncology
- Vol. 31 (9) , 2043-2052
Impact of periodontitis on the efficacy of neoadjuvant immunochemotherapy in non-small cell lung cancer: a multi-center real-world study
Neoadjuvant immunochemotherapy has revolutionized non-small cell lung cancer(NSCLC) treatment. Periodontitis(PD) is one of the most prevalent oral diseases worldwide; however, its influence on the efficacy of neoadjuvant immunochemotherapy in NSCLC remains unclear. This study aimed to evaluate the association between PD status and severity with treatment outcomes following neoadjuvant immunochemotherapy in NSCLC. Patients with initial stage IIA-IIIB NSCLC(excluding T4N2 and N3) who underwent surgery after neoadjuvant immunochemotherapy at three institutions between 2019 and 2025 were retrospectively reviewed. Stabilized inverse probability of treatment weighting(IPTW) was employed to balance baseline characteristics. The primary endpoint was major pathological response(MPR) rates. A total of 51 non-PD and 331 PD cases were included. After IPTW adjustment, PD was associated with lower MPR(33.5% vs. 43.5%, adjusted P = 0.036) and complete pathological response rates, as well as poorer early survival. Increasing PD severity was identified as an independent risk factor for diminished therapeutic efficacy. Specifically, grade II-III PD, but not grade I PD, was associated with poorer pathological response and preliminary survival outcomes. Interaction analyses revealed that such associative patterns were modified by age and body mass index(BMI). Subsequent stratified analyses confirmed that grade II-III PD was correlated with impaired pathological response and early survival in younger(age < 65 years) and non-overweight(BMI ≤ 24.0 kg/m2) patients, but not in older(age ≥ 65 years) and overweight(BMI > 24.0 kg/m2) patients. PD may be an unfavorable prognostic factor associated with clinical outcomes of neoadjuvant immunochemotherapy in NSCLC. Grade II-III PD may be associated with worse pathological response and early survival, with more pronounced adverse effects in younger and non-overweight patients.
- 17 December 2024
- Published by Wiley in Advanced Healthcare Materials
- Vol. 14 (4) , e2404260
Synergistic Enhancement of Antibacterial and Osteo‐Immunomodulatory Activities of Titanium Implants via Dual‐Responsive Multifunctional Surfaces
Bone implant‐associated infections and inflammations, primarily caused by bacteria colonization, frequently result in unsuccessful procedures and pose significant health risks to patients. To mitigate these challenges, the development of engineered implants with spatiotemporal regulation capabilities, designed to inhibit bacterial survival and modulate immune responses in the early stage, while promoting bone defect healing in the late stage is proposed. The implants are functionalized with ε‐poly‐l‐lysine‐phenylboronic acid (PP) via dynamic boronic ester bonds, which facilitate its release through a reactive oxygen species (ROS) and pH‐responsive strategy, thereby establishing an antibacterial microenvironment on and around the implants. Additionally, the dynamic metal coordination interaction facilitates the loading and sustained release of Sr2+ under an acidic environment, providing immunomodulatory and osteogenic effects. The ROS/pH‐responsive feature, coupled with the implant‐bone tissue integration process, affords precise spatiotemporal regulation of the Ti‐TA‐Sr‐PP implants. This strategy represents a promising approach for the preparation of advanced bone implants.
- 17 December 2024
- Published by Wiley in Advanced Healthcare Materials
- Vol. 14 (4) , e2404260
Synergistic Enhancement of Antibacterial and Osteo‐Immunomodulatory Activities of Titanium Implants via Dual‐Responsive Multifunctional Surfaces
Bone implant‐associated infections and inflammations, primarily caused by bacteria colonization, frequently result in unsuccessful procedures and pose significant health risks to patients. To mitigate these challenges, the development of engineered implants with spatiotemporal regulation capabilities, designed to inhibit bacterial survival and modulate immune responses in the early stage, while promoting bone defect healing in the late stage is proposed. The implants are functionalized with ε‐poly‐l‐lysine‐phenylboronic acid (PP) via dynamic boronic ester bonds, which facilitate its release through a reactive oxygen species (ROS) and pH‐responsive strategy, thereby establishing an antibacterial microenvironment on and around the implants. Additionally, the dynamic metal coordination interaction facilitates the loading and sustained release of Sr2+ under an acidic environment, providing immunomodulatory and osteogenic effects. The ROS/pH‐responsive feature, coupled with the implant‐bone tissue integration process, affords precise spatiotemporal regulation of the Ti‐TA‐Sr‐PP implants. This strategy represents a promising approach for the preparation of advanced bone implants.
- 25 September 2024
- Published by Wiley in Orthodontics & Craniofacial Research
- Vol. 28 (1) , 175-186
Dual role of Sfrp4 in bone remodelling during orthodontic tooth movement
Objectives: The objective of this study was to determine changes in gene expression by establishing an orthodontic tooth movement (OTM) rat model with appropriate and excessive orthodontic force.Materials and Methods: Using a closed coil nickel‐titanium spring, the OTM was carried out to apply a mesial force of 50 or 100 g to the maxillary first molars. Micro‐CT, histological and immunohistochemical staining were used to evaluate the bone formation at the tension site and the bone resorption and bone formation at pressure site. Then RNA sequencing and bioinformatic analysis were performed.Results: According to the results of the Mirco‐CT scan of OTM rat models, both the 50 g group and the 100 g group showed variable degrees of reduction in alveolar bone density on the tension and pressure sides. The results of histological and immunohistochemical staining demonstrated that the periodontal tissue and osteogenic ability of the 50 g group were restored at the 14 days, while the 100 g group caused severe periodontal tissue damage. The GO and KEGG analysis results, as well as the number of differentially expressed genes (DEGs), varied depending on the loading time and value of appliance, according to the results of the RNA sequencing. And the immunohistochemical staining results showed that Sfrp4 functioned by efficiently influencing both bone formation and bone absorption.Conclusions: Appropriate orthodontic force value could cause appropriate movement of teeth in rats without adverse periodontal damage. Simultaneously, distinct gene expression patterns were observed at various force levels and time intervals.
- 25 September 2024
- Published by Wiley in Orthodontics & Craniofacial Research
- Vol. 28 (1) , 175-186
Dual role of Sfrp4 in bone remodelling during orthodontic tooth movement
Objectives: The objective of this study was to determine changes in gene expression by establishing an orthodontic tooth movement (OTM) rat model with appropriate and excessive orthodontic force.Materials and Methods: Using a closed coil nickel‐titanium spring, the OTM was carried out to apply a mesial force of 50 or 100 g to the maxillary first molars. Micro‐CT, histological and immunohistochemical staining were used to evaluate the bone formation at the tension site and the bone resorption and bone formation at pressure site. Then RNA sequencing and bioinformatic analysis were performed.Results: According to the results of the Mirco‐CT scan of OTM rat models, both the 50 g group and the 100 g group showed variable degrees of reduction in alveolar bone density on the tension and pressure sides. The results of histological and immunohistochemical staining demonstrated that the periodontal tissue and osteogenic ability of the 50 g group were restored at the 14 days, while the 100 g group caused severe periodontal tissue damage. The GO and KEGG analysis results, as well as the number of differentially expressed genes (DEGs), varied depending on the loading time and value of appliance, according to the results of the RNA sequencing. And the immunohistochemical staining results showed that Sfrp4 functioned by efficiently influencing both bone formation and bone absorption.Conclusions: Appropriate orthodontic force value could cause appropriate movement of teeth in rats without adverse periodontal damage. Simultaneously, distinct gene expression patterns were observed at various force levels and time intervals.
- 21 March 2024
- Published by Wiley in Advanced Healthcare Materials
- Vol. 13 (16) , e2303390
The H2O2 Self‐Sufficient 3D Printed β‐TCP Scaffolds with Synergistic Anti‐Tumor Effect and Reinforced Osseointegration
Tumor recurrence and massive bone defects are two critical challenges for postoperative treatment of oral and maxillofacial tumor, posing serious threats to the health of patients. Herein, in order to eliminate residual tumor cells and promote osteogenesis simultaneously, the hydrogen peroxide (H2O2) self‐sufficient TCP‐PDA‐CaO2‐CeO2 (TPCC) scaffolds are designed by preparing CaO2 or/and CeO2 nanoparticles (NPs)/chitosan solution and modifying the NPs into polydopamine (PDA)‐modified 3D printed TCP scaffolds by rotary coating method. CaO2 NPs loaded on the scaffolds can release Ca2+ and sufficient H2O2 in the acidic tumor microenvironment (TME). The generated H2O2 can further produce hydroxyl radicals (·OH) under catalysis effect by peroxidase (POD) activity of CeO2 NPs, in which the photothermal effect of the PDA coating enhances its POD catalytic effect. Overall, NPs loaded on the scaffold chemically achieve a cascade reaction of H2O2 self‐sufficiency and ·OH production, while functionally achieving synergistic effects on anti‐tumor and bone promotion. In vitro and in vivo studies show that the scaffolds exhibit effective osteo‐inductivity, induced osteoblast differentiation and promote osseointegration. Therefore, the multifunctional composite scaffolds not only validate the concept of chemo‐dynamic therapy (CDT) cascade therapy, but also provide a promising clinical strategy for postoperative treatment of oral and maxillofacial tumor.
- 21 March 2024
- Published by Wiley in Advanced Healthcare Materials
- Vol. 13 (16) , e2303390
The H2O2 Self‐Sufficient 3D Printed β‐TCP Scaffolds with Synergistic Anti‐Tumor Effect and Reinforced Osseointegration
Tumor recurrence and massive bone defects are two critical challenges for postoperative treatment of oral and maxillofacial tumor, posing serious threats to the health of patients. Herein, in order to eliminate residual tumor cells and promote osteogenesis simultaneously, the hydrogen peroxide (H2O2) self‐sufficient TCP‐PDA‐CaO2‐CeO2 (TPCC) scaffolds are designed by preparing CaO2 or/and CeO2 nanoparticles (NPs)/chitosan solution and modifying the NPs into polydopamine (PDA)‐modified 3D printed TCP scaffolds by rotary coating method. CaO2 NPs loaded on the scaffolds can release Ca2+ and sufficient H2O2 in the acidic tumor microenvironment (TME). The generated H2O2 can further produce hydroxyl radicals (·OH) under catalysis effect by peroxidase (POD) activity of CeO2 NPs, in which the photothermal effect of the PDA coating enhances its POD catalytic effect. Overall, NPs loaded on the scaffold chemically achieve a cascade reaction of H2O2 self‐sufficiency and ·OH production, while functionally achieving synergistic effects on anti‐tumor and bone promotion. In vitro and in vivo studies show that the scaffolds exhibit effective osteo‐inductivity, induced osteoblast differentiation and promote osseointegration. Therefore, the multifunctional composite scaffolds not only validate the concept of chemo‐dynamic therapy (CDT) cascade therapy, but also provide a promising clinical strategy for postoperative treatment of oral and maxillofacial tumor.
- Open Access
- 1 January 2024
- Published by American Association for the Advancement of Science (AAAS) in Biomaterials Research
- Vol. 28, 0057
A Novel Lipopeptide–Functionalized Metal–Organic Framework for Periodontitis Therapy through the Htra1/FAK/YAP Pathway
Periodontitis is a chronic inflammatory disease characterized by plaque accumulation, resulting in immune microenvironment disorders and resorption of alveolar bone. To promote bone healing under inflammatory environments, a functional biomaterial based on disease pathophysiology is designed. A novel fatty acid C10-modified polypeptide, C 10 -KR8, is discovered to have excellent abilities in modulating macrophage repolarization and promoting bone regeneration in periodontitis. To build a multifunctional material localized drug delivery system, C 10 -KR8@ZIF-8 (C 10 -KR8-loaded zeolitic imidazolate framework-8) nanoparticles are constructed to sustainedly release the C 10 -KR8 peptide and Zn elements. By synergistic effects of providing a dynamic immuno-modulatory environment and promoting osteogenesis under pathological conditions, the obtained pH-responsive nanoparticles display excellent bone regeneration capability. Furthermore, coimmunoprecipitation/liquid chromatography-tandem mass spectrometry analysis and proteomics analysis revealed that the C 10 -KR8 peptide directly interacts with the high-temperature requirement protein A1 (Htra1), and C 10 -KR8@ZIF-8 nanoparticles promote the osteogenic differentiation of bone mesenchymal stem cells by activating the focal adhesion kinase (FAK)/phosphatidylinositide 3-kinase (PI3K)/AKT pathway and enhancing the nuclear localization of Yes-associated protein (YAP). Taken together, this study demonstrates C 10 -KR8 peptide regulate osteoimmunology and bone regeneration by Htra1/FAK/YAP pathway and that ZIF-8-based peptide loading platform is a promising strategy for periodontitis.
- 1 January 2024
- Published by American Association for the Advancement of Science (AAAS) in Biomaterials Research
- Vol. 28, 0057
Open AccessA Novel Lipopeptide–Functionalized Metal–Organic Framework for Periodontitis Therapy through the Htra1/FAK/YAP Pathway
Periodontitis is a chronic inflammatory disease characterized by plaque accumulation, resulting in immune microenvironment disorders and resorption of alveolar bone. To promote bone healing under inflammatory environments, a functional biomaterial based on disease pathophysiology is designed. A novel fatty acid C10-modified polypeptide, C 10 -KR8, is discovered to have excellent abilities in modulating macrophage repolarization and promoting bone regeneration in periodontitis. To build a multifunctional material localized drug delivery system, C 10 -KR8@ZIF-8 (C 10 -KR8-loaded zeolitic imidazolate framework-8) nanoparticles are constructed to sustainedly release the C 10 -KR8 peptide and Zn elements. By synergistic effects of providing a dynamic immuno-modulatory environment and promoting osteogenesis under pathological conditions, the obtained pH-responsive nanoparticles display excellent bone regeneration capability. Furthermore, coimmunoprecipitation/liquid chromatography-tandem mass spectrometry analysis and proteomics analysis revealed that the C 10 -KR8 peptide directly interacts with the high-temperature requirement protein A1 (Htra1), and C 10 -KR8@ZIF-8 nanoparticles promote the osteogenic differentiation of bone mesenchymal stem cells by activating the focal adhesion kinase (FAK)/phosphatidylinositide 3-kinase (PI3K)/AKT pathway and enhancing the nuclear localization of Yes-associated protein (YAP). Taken together, this study demonstrates C 10 -KR8 peptide regulate osteoimmunology and bone regeneration by Htra1/FAK/YAP pathway and that ZIF-8-based peptide loading platform is a promising strategy for periodontitis.
- Open Access
- 11 December 2023
- Published by Wiley in Journal of Periodontal Research
- Vol. 59 (2) , 311-324
Identifying genes for regulating osteogenic differentiation of human periodontal ligament stem cells in inflammatory environments by bioinformatics analysis
Background and ObjectivesPeriodontitis is an immuno-inflammatory disease caused by dental plaque biofilms and inflammations. The regeneration of bone tissue in inflammatory environment is of great significance for the treatment of periodontal disease, but the specific molecular mechanism of bone formation in periodontitis still needs further exploration. The objective of this study was to identify key osteogenesis-related genes (ORGs) in periodontitis.MethodsWe used two datasets from the Gene Expression Omnibus (GEO) database to find differentially expressed mRNAs and miRNAs, further performed Gene Ontology (GO) and the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis. Then we predicted the downstream genes of the differentially expressed miRNAs (DEMs) by the TargetScan database and established a miRNA-mRNA regulatory network. Finally, the osteogenic mechanism of periodontitis was explored through quantitative real-time PCR (qRT-PCR) by inducing inflammatory environment and osteogenic differentiation of hPDLSCs.ResultsThrough differential expression analysis and prediction of downstream target genes of DEMs, we created a miRNA-mRNA regulatory network consisting of 29 DEMs and 11 differentially expressed osteogenesis-related genes (DEORGs). In addition, the qRT-PCR results demonstrated that BTBD3, PLAT, AKAP12, SGK1, and GLCE expression levels were significantly upregulated, while those of TIMP3, ZCCHC14, LIN7A, DNAH6, NNT, and ITGA6 were downregulated under the dual effects of inflammatory stimulation and osteogenic induction.ConclusionDEORGs might be important factors in the osteogenic phase of periodontitis, and the miRNA-mRNA network may shed light on the clarification of the role and mechanism of osteogenesis in periodontitis and contribute to the development of novel therapeutic strategies.
- 11 December 2023
- Published by Wiley in Journal of Periodontal Research
- Vol. 59 (2) , 311-324
Open AccessIdentifying genes for regulating osteogenic differentiation of human periodontal ligament stem cells in inflammatory environments by bioinformatics analysis
Background and ObjectivesPeriodontitis is an immuno-inflammatory disease caused by dental plaque biofilms and inflammations. The regeneration of bone tissue in inflammatory environment is of great significance for the treatment of periodontal disease, but the specific molecular mechanism of bone formation in periodontitis still needs further exploration. The objective of this study was to identify key osteogenesis-related genes (ORGs) in periodontitis.MethodsWe used two datasets from the Gene Expression Omnibus (GEO) database to find differentially expressed mRNAs and miRNAs, further performed Gene Ontology (GO) and the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis. Then we predicted the downstream genes of the differentially expressed miRNAs (DEMs) by the TargetScan database and established a miRNA-mRNA regulatory network. Finally, the osteogenic mechanism of periodontitis was explored through quantitative real-time PCR (qRT-PCR) by inducing inflammatory environment and osteogenic differentiation of hPDLSCs.ResultsThrough differential expression analysis and prediction of downstream target genes of DEMs, we created a miRNA-mRNA regulatory network consisting of 29 DEMs and 11 differentially expressed osteogenesis-related genes (DEORGs). In addition, the qRT-PCR results demonstrated that BTBD3, PLAT, AKAP12, SGK1, and GLCE expression levels were significantly upregulated, while those of TIMP3, ZCCHC14, LIN7A, DNAH6, NNT, and ITGA6 were downregulated under the dual effects of inflammatory stimulation and osteogenic induction.ConclusionDEORGs might be important factors in the osteogenic phase of periodontitis, and the miRNA-mRNA network may shed light on the clarification of the role and mechanism of osteogenesis in periodontitis and contribute to the development of novel therapeutic strategies.
- 23 September 2023
- Published by Springer Nature in Journal of Materials Science
- Vol. 58 (36) , 14467-14479
Prussian blue-integrated porous β-TCP scaffolds for photothermal anti-tumor and NO-augmented osteogenesis
- 23 September 2023
- Published by Springer Nature in Journal of Materials Science
- Vol. 58 (36) , 14467-14479
Prussian blue-integrated porous β-TCP scaffolds for photothermal anti-tumor and NO-augmented osteogenesis
- Open Access
- 11 June 2020
- Published by Springer Nature in Cell Death Discovery
- Vol. 6 (1) , 1-14
Zoledronic acid regulates the synthesis and secretion of IL-1β through Histone methylation in macrophages
Long-term administration of nitrogen-containing bisphosphonates increases the risk of detrimental side effects, such as bisphosphonate-related osteonecrosis of the jaw (BRONJ). BRONJ development is associated with inflammation, but its pathophysiology remains unknown. Here, we examined whether histone methylation is responsible for zoledronic acid (Zol)-induced inflammatory responses. We found that Kdm6a and Kdm6b markedly increased interleukin 1β expression and Gasdermin D cleavage, which are both activated by Caspase 1, in macrophages. Inhibitors of Kdm6a and Kdm6b robustly abolished Zol-enhanced interleukin 1β synthesis and secretion from macrophages. When Kdm6a and Kdm6b were pharmacologically inhibited in vivo, poor healing of the alveolar socket and inflammatory responses were ameliorated in Zol-treated mice. Taken together, we showed the pathologic role of Kdm6a and Kdm6b in Zol-promoted inflammatory responses and demonstrated that Kdm6a and Kdm6b are potential therapeutic targets for the treatment of BRONJ.
- 11 June 2020
- Published by Springer Nature in Cell Death Discovery
- Vol. 6 (1) , 1-14
Open AccessZoledronic acid regulates the synthesis and secretion of IL-1β through Histone methylation in macrophages
Long-term administration of nitrogen-containing bisphosphonates increases the risk of detrimental side effects, such as bisphosphonate-related osteonecrosis of the jaw (BRONJ). BRONJ development is associated with inflammation, but its pathophysiology remains unknown. Here, we examined whether histone methylation is responsible for zoledronic acid (Zol)-induced inflammatory responses. We found that Kdm6a and Kdm6b markedly increased interleukin 1β expression and Gasdermin D cleavage, which are both activated by Caspase 1, in macrophages. Inhibitors of Kdm6a and Kdm6b robustly abolished Zol-enhanced interleukin 1β synthesis and secretion from macrophages. When Kdm6a and Kdm6b were pharmacologically inhibited in vivo, poor healing of the alveolar socket and inflammatory responses were ameliorated in Zol-treated mice. Taken together, we showed the pathologic role of Kdm6a and Kdm6b in Zol-promoted inflammatory responses and demonstrated that Kdm6a and Kdm6b are potential therapeutic targets for the treatment of BRONJ.
- 11 May 2020
- Published by Wiley in Clinical and Experimental Pharmacology and Physiology
- Vol. 47 (9) , 1591-1599
ARHGAP17 inhibits pathological cyclic strain‐induced apoptosis in human periodontal ligament fibroblasts via Rac1/Cdc42
Rho GTPase‐activating protein (Rho‐GAP) and Rho GDP dissociation inhibitor (Rho‐ GDI) are two main negative regulators of Rho GTPase. Our previous work has found that Rho‐GDI and Rho GTPase are involved in the response of human periodontal ligament (PDL) cells to mechanical stress. However, whether Rho‐GAP also has a role in this process remains unknown. Here, we attempted to find the Rho‐GAP gene that may be involved in pathological stretch‐induced apoptosis of PDL cells. Human PDL fibroblasts were exposed to 20% cyclic strain for 6 hours or 24 hours, after which the expression levels of ARHGAP10, ARHGAP17, ARHGAP21, ARHGAP24 and ARHGAP28 were determined. Results showed that ARHGAP17 expression decreased the most obviously after treatment of stretch. In addition, ARHGAP17 overexpression abolished 20% cyclic strain‐induced apoptosis. Therefore, ARHGAP17 has an important role in pathological stretch‐induced apoptosis of human PDL fibroblasts. Moreover, we found that ARHGAP17 overexpression also alleviated cyclic strain‐induced activation of Rac1/Cdc42, a major downstream target of ARHGAP17. Furthermore, two Rac1 inhibitors, NSC23766 and EHT 1864, both attenuated ARHGAP17 knockdown‐mediated apoptosis in human PDL fibroblasts. Collectively, our data demonstrate that ARHGAP17 inhibits pathological cyclic strain‐induced apoptosis in human PDL fibroblasts through inactivating Rac1/Cdc42. This study highlights the importance of Rho signalling in the response of human PDL fibroblasts to mechanical stress.
- 11 May 2020
- Published by Wiley in Clinical and Experimental Pharmacology and Physiology
- Vol. 47 (9) , 1591-1599
ARHGAP17 inhibits pathological cyclic strain‐induced apoptosis in human periodontal ligament fibroblasts via Rac1/Cdc42
Rho GTPase‐activating protein (Rho‐GAP) and Rho GDP dissociation inhibitor (Rho‐ GDI) are two main negative regulators of Rho GTPase. Our previous work has found that Rho‐GDI and Rho GTPase are involved in the response of human periodontal ligament (PDL) cells to mechanical stress. However, whether Rho‐GAP also has a role in this process remains unknown. Here, we attempted to find the Rho‐GAP gene that may be involved in pathological stretch‐induced apoptosis of PDL cells. Human PDL fibroblasts were exposed to 20% cyclic strain for 6 hours or 24 hours, after which the expression levels of ARHGAP10, ARHGAP17, ARHGAP21, ARHGAP24 and ARHGAP28 were determined. Results showed that ARHGAP17 expression decreased the most obviously after treatment of stretch. In addition, ARHGAP17 overexpression abolished 20% cyclic strain‐induced apoptosis. Therefore, ARHGAP17 has an important role in pathological stretch‐induced apoptosis of human PDL fibroblasts. Moreover, we found that ARHGAP17 overexpression also alleviated cyclic strain‐induced activation of Rac1/Cdc42, a major downstream target of ARHGAP17. Furthermore, two Rac1 inhibitors, NSC23766 and EHT 1864, both attenuated ARHGAP17 knockdown‐mediated apoptosis in human PDL fibroblasts. Collectively, our data demonstrate that ARHGAP17 inhibits pathological cyclic strain‐induced apoptosis in human PDL fibroblasts through inactivating Rac1/Cdc42. This study highlights the importance of Rho signalling in the response of human PDL fibroblasts to mechanical stress.
- Open Access
- 21 August 2018
- Published by Spandidos Publications in Oncology Letters
- Vol. 16 (5) , 5891-5899
A 20(S)‑protopanaxadiol derivative PPD12 reverses ABCB1‑mediated multidrug resistance with oral bioavailability and low toxicity
The ATP‑binding cassette subfamily B member 1 (ABCB1) is a transporter that mediates multidrug resistance (MDR) against chemotherapy, which leads to decreased patient survival. To inhibit ABCB1 activity in MDR cancer cells, the authors previously designed and synthesized a derivative from 20(S)‑protopanaxadiol (PPD) PPD12 and verified its efficacy in ABCB1‑overexpressing cancer cells. In the present study, the reversal effect of PPD12 on MDR was further evaluated and its pharmacokinetics and toxicity in vitro and in vivo were investigated. Incubation with PPD12 may significantly ameliorate the drug resistance of KB/VCR cells in a short time and maintain its reversed MDR ability for increasing time periods. In assays on a series of CYP450 activities, PPD12 demonstrated slight inhibition effects on the majority of enzymes. The bioavailability of PPD12 was nearly 100% by oral administration in a mouse model. Single PPD12 oral gavage at either high doses or subchronic low doses, was well tolerated by the mice. In addition, PPD12 at the therapeutic dosage did not significantly increase the toxicity of the chemotherapeutic agent Adriamycin when mice received a combination of the two compounds. In conclusion, PPD12 represents a novel type of ABCB1 inhibitor that has significant bioactivity in terms of MDR, high oral bioavailability and low toxicity.
- 21 August 2018
- Published by Spandidos Publications in Oncology Letters
- Vol. 16 (5) , 5891-5899
Open AccessA 20(S)‑protopanaxadiol derivative PPD12 reverses ABCB1‑mediated multidrug resistance with oral bioavailability and low toxicity
The ATP‑binding cassette subfamily B member 1 (ABCB1) is a transporter that mediates multidrug resistance (MDR) against chemotherapy, which leads to decreased patient survival. To inhibit ABCB1 activity in MDR cancer cells, the authors previously designed and synthesized a derivative from 20(S)‑protopanaxadiol (PPD) PPD12 and verified its efficacy in ABCB1‑overexpressing cancer cells. In the present study, the reversal effect of PPD12 on MDR was further evaluated and its pharmacokinetics and toxicity in vitro and in vivo were investigated. Incubation with PPD12 may significantly ameliorate the drug resistance of KB/VCR cells in a short time and maintain its reversed MDR ability for increasing time periods. In assays on a series of CYP450 activities, PPD12 demonstrated slight inhibition effects on the majority of enzymes. The bioavailability of PPD12 was nearly 100% by oral administration in a mouse model. Single PPD12 oral gavage at either high doses or subchronic low doses, was well tolerated by the mice. In addition, PPD12 at the therapeutic dosage did not significantly increase the toxicity of the chemotherapeutic agent Adriamycin when mice received a combination of the two compounds. In conclusion, PPD12 represents a novel type of ABCB1 inhibitor that has significant bioactivity in terms of MDR, high oral bioavailability and low toxicity.